- Home
- OWLT vs BMEA Comparison
OWLT vs BMEA Comparison
Compare OWLT & BMEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OWLT
- BMEA
- Stock Information
- Founded
- OWLT 2013
- BMEA 2017
- Country
- OWLT United States
- BMEA United States
- Employees
- OWLT N/A
- BMEA N/A
- Industry
- OWLT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BMEA Biotechnology: Pharmaceutical Preparations
- Sector
- OWLT Health Care
- BMEA Health Care
- Exchange
- OWLT Nasdaq
- BMEA Nasdaq
- Market Cap
- OWLT 119.8M
- BMEA 114.3M
- IPO Year
- OWLT N/A
- BMEA 2021
- Fundamental
- Price
- OWLT $7.11
- BMEA $1.82
- Analyst Decision
- OWLT
- BMEA Strong Buy
- Analyst Count
- OWLT 0
- BMEA 11
- Target Price
- OWLT N/A
- BMEA $16.55
- AVG Volume (30 Days)
- OWLT 73.0K
- BMEA 562.9K
- Earning Date
- OWLT 08-07-2025
- BMEA 10-28-2025
- Dividend Yield
- OWLT N/A
- BMEA N/A
- EPS Growth
- OWLT N/A
- BMEA N/A
- EPS
- OWLT N/A
- BMEA N/A
- Revenue
- OWLT $89,774,000.00
- BMEA N/A
- Revenue This Year
- OWLT $28.93
- BMEA N/A
- Revenue Next Year
- OWLT $22.87
- BMEA N/A
- P/E Ratio
- OWLT N/A
- BMEA N/A
- Revenue Growth
- OWLT 36.78
- BMEA N/A
- 52 Week Low
- OWLT $2.75
- BMEA $1.29
- 52 Week High
- OWLT $10.30
- BMEA $13.07
- Technical
- Relative Strength Index (RSI)
- OWLT 44.39
- BMEA 49.48
- Support Level
- OWLT $6.93
- BMEA $1.79
- Resistance Level
- OWLT $8.00
- BMEA $2.08
- Average True Range (ATR)
- OWLT 0.53
- BMEA 0.12
- MACD
- OWLT -0.04
- BMEA 0.00
- Stochastic Oscillator
- OWLT 26.40
- BMEA 28.92
About OWLT Owlet Inc.
Owlet Inc is engaged in providing a digital parenting platform that aims to give parents real-time data and insights to help parents feel more calm and confident. Its diversified portfolio of products includes Owlet Smart Sock, the first baby monitor to track an infant's oxygen levels, heart rate, and sleep trends; the Owlet Cam, which turns any smartphone into a baby monitor with high-definition clarity; the Owlet Monitor Duo, which offers the intelligence of the Owlet Smart Sock paired with the Owlet Cam; and Owlet Dream Lab, an interactive online program designed to be a parent's guide to building healthy sleep habits for their infants.
About BMEA Biomea Fusion Inc.
Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases. The company uses its proprietary FUSION System discovery platform to develop a pipeline of novel small-molecule product candidates. Its principal clinical program's drug candidate, icovamenib, is being developed as an orally bioavailable, selective covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity. The company is also developing BMF-650, an investigational, oral small-molecule GLP-1 RA, which has the potential to be a therapeutic option for diabetes and obesity.